Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Poster Category 2

Growth (1)

Anophthalmia, Abnormal Pituitary Development, and Suboptimal Response to GH Therapy in Two Children With Microdeletions of 14q22q23
aDepartment of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic; bDepartment of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic; cGenetic and Pediatric Out-Patient Clinic, Benesov, Czech Republic
hrp0082p2-d2-461
Adiponectin Levels as Early Marker of Insulin Resistance in Children Born Small for Gestational Age in Our Cohort
Department of Pediatrics and Biochemistry, Maulana Azad Medical University of Delhi, New Delhi, India
hrp0082p2-d2-462
Interrelationships Between BMI and Other Overweight Related Anthropometric Variables in Childhood
aUniversity of Bergen, Bergen, Norway; bKatholieke Universiteit Leuven, Leuven, Belgium; cStavanger University Hospital, Stavanger, Norway
hrp0082p2-d2-464
Assessment of Omentin-1, Vaspin, and Visfatin Levels in Pediatric Patients with GH Deficiency
Department of Pediatrics, Endocrinology and Diabetology with the Cardiology Division, Medical University in Bialystok, Bialystok, Poland
hrp0082p2-d2-465
Normal Growth in Aromatase Excess Syndrome by Pharmacological Inhibition of Aromatase Activity
University Children’s Hospital, Pediatric Endocrinology, Tübingen, Germany
hrp0082p2-d2-466
The Effect of the Environmental Factors on Growth Pattern of Turkish Children Having the Same Genetic Origin
aSelcuk University Medical School, Konya, Turkey; bBezmialem Foundation University Medical School, Istanbul, Turkey; cErciyes University Medical School, Kayseri, Turkey
hrp0082p2-d2-467
Successful GH Treatment for Severe Growth Failure in Paediatric Patients with Anorexia Nervosa
aPaediatric Endocrinology–Diabetology Department, Robert Debre Hospital, Assistance Publique-Hopitaux de Paris, Universite Paris-Diderot, Paris, France; bPedopsychiatric Department, Robert Debre Hospital, Assistance Publique-Hopitaux de Paris, Universite Paris-Diderot, Paris, France; cReference Center for Rare Endocrine Growth Diseases, Paris, France
hrp0082p2-d2-468
Severe Short Stature due to a Heterozygous igf1r Mutation With a Good Response to rhgh Therapy: a Family Study
aPediatric Endocrinologym, Hospital General de Granollers, Barcelona, Spain; bPediatric Endocrinology, Hospital Vall d’Hebron, Barcelona, Spain; cVHIR; CIBERER (U712), Autonomous University, Barcelona, Spain; dHospital Universitario La Paz; INGEMM, IdiPAZ, UAM, Madrid, Spain; eCIBERER (U753), ISCIII, Madrid, Spain
hrp0082p2-d2-470
When and Why Should We Investigate the SRCAP Gene in Cases of Short Stature?
aFaculdade de Medicina – Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil; bChildren’s Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada; cAmbulatório de Genética Médica da Secretaria Municipal de Saúde de Porto Aelgre, Porto Alegre, Rio Grande do Sul, Brazil
hrp0082p2-d2-471
Body Proportions Estimated by Photometry
Maastricht University, Maastricht, The Netherlands
hrp0082p2-d2-472
GH Deficiency in a Child With De Novo 2q31.1 Microdeletion
aEndocrinology Department, ‘P & A Kyriakou’ Children’s Hospital, Athens, Greece; bMicrobiology, ‘P & A Kyriakou’ Children’s Hospital, Athens, Greece
hrp0082p2-d2-473